Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperthyroidism after propranolol withdrawal.

L Shenkman, P Podrid, J Lowenstein

    JAMA
    |July 18, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Non-invasive method for assessment of inflammation.

    Biomedical optics express·2023
    Same author

    Myocardial torsion and cardiac fulcrum.

    Morphologie : bulletin de l'Association des anatomistes·2020
    Same author

    Impact of Fitness Status on the Optically Measured Hemodynamic Indexes.

    Journal of healthcare engineering·2018
    Same author

    SU-E-T-223: High-Energy Photon Standard Dosimetry Data: A Quality Assurance Tool.

    Medical physics·2017
    Same author

    SU-E-T-199: The Radiological Physics Center's Credentialing Dosimetry Reviews: Their Effect on Clinical Trial Deviation Rates.

    Medical physics·2017
    Same author

    MO-D-BRB-02: The Radiological Physics Center's Quality Audit Program: Where Can We Improve?

    Medical physics·2017
    Same journal

    WHO Issues Guidelines for Treating Ebola and Marburg Viruses.

    JAMA·2026
    Same journal

    FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose.

    JAMA·2026
    Same journal

    HIV May Hide in More Cells Than Previously Thought-Here's What That Could Mean for a Cure.

    JAMA·2026
    Same journal

    US Dietary Supplement Use Increasing, Especially in Older Adults.

    JAMA·2026
    Same journal

    Heat Stress From Climate Change Surges Globally.

    JAMA·2026
    Same journal

    Strength Training Linked With Lower Cardiovascular Disease Risk in Women.

    JAMA·2026
    See all related articles

    Discontinuing propranolol hydrochloride (a beta-blocker) can unmask latent hyperthyroidism, leading to thyrotoxicosis. This requires careful monitoring, especially in patients with heart conditions.

    Area of Science:

    • Endocrinology
    • Cardiology
    • Pharmacology

    Background:

    • Propranolol hydrochloride, a beta-adrenergic blocker, is commonly used for cardiovascular conditions.
    • Hyperthyroidism, or thyrotoxicosis, is a condition characterized by an overactive thyroid gland.
    • Beta-blockers can mask the typical symptoms of hyperthyroidism.

    Observation:

    • Three patients without prior thyroid issues developed thyrotoxicosis after stopping or reducing propranolol hydrochloride.
    • The beta-adrenergic blockade from propranolol masked the clinical presentation of hyperthyroidism in these patients.
    • Latent thyrotoxicosis became apparent upon propranolol withdrawal or dose reduction.

    Findings:

    • Discontinuation or dose reduction of propranolol hydrochloride can precipitate overt thyrotoxicosis.

    Related Experiment Videos

  • The masking effect of beta-blockade necessitates vigilance for underlying thyroid dysfunction.
  • Sudden manifestation of thyrotoxicosis post-propranolol withdrawal can exacerbate myocardial ischemia in susceptible patients.

    • Implications:

    • Clinicians should consider the potential for unmasking hyperthyroidism when discontinuing propranolol.
    • Early recognition of masked thyrotoxicosis is crucial, particularly in patients with ischemic heart disease.
    • This highlights the importance of comprehensive patient assessment beyond the primary indication for beta-blocker therapy.